Pistagremic acid from Pistacia integerrima as a natural multi-target candidate tackling crucial enzymes involved in Alzheimer’s disease

Key Points

• Findings indicate that pistagremic acid effectively inhibits crucial enzymes associated with Alzheimer's disease, offering potential therapeutic benefits.
• The study identifies a multi-target approach using natural compounds, highlighting the importance of pistagremic acid in drug discovery for Alzheimer's.
• Analysis of enzyme activity demonstrates that pistagremic acid has significant effects on the biochemical pathways involved in Alzheimer's disease.
• These results support exploring natural compounds like pistagremic acid for treating Alzheimer's, although clinical validation is needed.